|
Parameters
|
No. of patients
|
CRT
|
P
|
IRE1α
|
P
|
|---|
|
Low
|
High
|
Negative
|
Positive
|
|---|
|
Cases
|
81
|
31
|
50
| |
43
|
38
| |
|
Age (years)
|
|
≤ 65
|
63
|
25
|
38
|
0.625
|
36
|
27
|
0.171
|
|
> 65
|
18
|
6
|
12
| |
7
|
11
| |
|
Gender
|
|
Male
|
47
|
19
|
28
|
0.639
|
21
|
26
|
0.075
|
|
Female
|
34
|
12
|
22
| |
22
|
12
| |
|
Tumor location
|
|
Head
|
57
|
21
|
36
|
0.683
|
30
|
27
|
0.899
|
|
Body-tail
|
24
|
10
|
14
| |
13
|
11
| |
|
Tumor size (cm)
|
|
< 3
|
24
|
7
|
17
|
0.274
|
13
|
11
|
0.899
|
|
≥ 3
|
57
|
24
|
33
| |
30
|
27
| |
|
Differentiation
|
|
Well
|
22
|
7
|
15
|
0.466
|
12
|
10
|
0.872
|
|
Moderate and poor
|
59
|
24
|
35
| |
31
|
28
| |
|
T stage
|
|
T1 + T2
|
72
|
30
|
42
|
0.157
|
37
|
35
|
0.609
|
|
T3 + T4
|
9
|
1
|
8
| |
6
|
3
| |
|
Lymph nodes metastasis
|
|
N0 (negative)
|
65
|
30
|
35
|
0.003
|
30
|
35
|
0.012
|
|
N1 (positive)
|
16
|
1
|
15
| |
13
|
3
| |
|
UICC stage
|
|
I + IIA
|
62
|
29
|
33
|
0.004
|
27
|
35
|
0.002
|
|
IIB + III
|
19
|
2
|
17
| |
16
|
3
| |
|
Perineural invasion
|
|
Absent
|
70
|
28
|
42
|
0.636
|
37
|
33
|
0.917
|
|
Present
|
11
|
3
|
8
| |
6
|
5
| |
|
Vascular permeation
|
|
Absent
|
49
|
15
|
34
|
0.079
|
28
|
21
|
0.365
|
|
Present
|
32
|
16
|
16
| |
15
|
17
| |
|
Pre-therapeutic CA19–9 level (U/ml)
|
|
< 37
|
22
|
12
|
10
|
0.066
|
8
|
14
|
0.066
|
|
≥ 37
|
59
|
19
|
40
| |
35
|
24
| |
|
Postoperative liver metastasis
|
|
Negative
|
54
|
23
|
31
|
0.258
|
27
|
27
|
0.431
|
|
Positive
|
27
|
8
|
19
| |
16
|
11
| |
